Table 2

Number of tumor patients in each of the four NSCLC subtypes and the cell lines selected to represent each subtype.

Clusters

Number of tumors

Representative Cancer Cell Lines for each subtype


Cluster A

19

HCC827, NCI-H1437, NCI-H1563, NCI-H1568, NCI-H1623, NCI-H1651, NCI-H1693, NCI-H1755, NCI-H1793, NCI-H1838, NCI-H1944, NCI-H1975, NCI-H1993, NCI-H2023, NCI-H2073, NCI-H2085, NCI-H2087, NCI-H2122, NCI-H2126, NCI-H2228, NCI-H2291, NCI-H23, NCI-H2342, NCI-H2347, NCI-H647, NCI-H920, NCI-H969, CLS-54, LX-289, SK-LU-1, H2882, Calu-6, H358, H460


Cluster B

60

NCI-H2405, NCI-H522, SK-MES-1, H157, H1819, H2009, H2887, HCC1171, HCC1359, HCC15, HCC193, HCC366, HCC461, HCC515, HCC78, HOP-62, HOP-92, NCI-H266


Cluster C

42

A549, Calu-3, NCI-H1734, NCI-H838, HCC95


Cluster D

124


Lu et al. BMC Medical Genomics 2010 3:23   doi:10.1186/1755-8794-3-23

Open Data